Home | Technology News Search Engine:
|
|
|
Home: Technology News:
|
|
(IT-NEWSWIRE.COM, September 15, 2018 ) The global Cancer Biomarkers Market was valued at USD 10.19 billion in 2016 and is projected to reach USD 28.03 billion by 2025, growing at a CAGR of 11.9% from 2017 to 2025.
Cancer Biomarkers are bio molecules which are indicative of cancerous cells in body. Cancer biomarkers can be molecules released by cancer tumors or any other molecules which can assure presence of cancerous tissue in the body. The major drivers for the market are increasing number of cancer patient and growing risk of Breast cancer amongst female population.
Download Sample Copy@http://bit.ly/2x6s1fX
Research institutes have also increased investments in the cancer diagnosis and treatment projects which is a positive driver for the cancer biomarker market. However, the discrepancy in the outcome of the procedure has restrained the market.
The major players in the market are as follows:
Thermo Fisher Scientific Bio-Rad Laboratories Roche Diagnostics Qiagen N.V. Illumina GE Healthcare Agilent Technologies Biomérieux SA Merck & Co. Abbott Laboratories Becton, Dickinson and Company Danaher Corporation Myriad Genetics Sysmex Corporation Hologic Quest Diagnostics
Ask for Discount @ http://bit.ly/2MngVbX
About Us: Verified Market Research Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.
Contact Information:
Verified Market Research Contact Person: Ankush Tel: +1650781 4080 Email us: sales@verifiedmarketresearch.com
Verified Market Research
Amaan Kazi
+1 (650) 781 4080
amaankazi@verifiedmarketresearch.com
Source: EmailWire.Com
Source: EmailWire.com
|
|
|
|
Technology News Headlines
|
|
|
Technology Business Video Feed
|
More Technology Video Feeds
|
|
|